TABLE I.
Age (years) | |
Median | 64 |
Range | 48–80 |
Sex | |
Male | 10 |
Female | 5 |
Stage | |
T3N0 | 1 |
T2N1 | 2 |
T3N1 | 11 |
T4N1 | 1 |
Tumour pathology | |
Squamous-cell | 10 |
Adenocarcinoma | 5 |
Margin status | |
Clear | 10 |
Close/positive | 5 |
Age (years) | |
Median | 64 |
Range | 48–80 |
Sex | |
Male | 10 |
Female | 5 |
Stage | |
T3N0 | 1 |
T2N1 | 2 |
T3N1 | 11 |
T4N1 | 1 |
Tumour pathology | |
Squamous-cell | 10 |
Adenocarcinoma | 5 |
Margin status | |
Clear | 10 |
Close/positive | 5 |